Cargando…
Additional Effect of Luseogliflozin on Semaglutide in Nonalcoholic Steatohepatitis Complicated by Type 2 Diabetes Mellitus: An Open-Label, Randomized, Parallel-Group Study
INTRODUCTION: Untreated nonalcoholic fatty liver may progress to nonalcoholic steatohepatitis (NASH) and cirrhosis and induce hepatocellular carcinoma and liver failure. Type 2 diabetes mellitus (T2DM), often complicated with nonalcoholic fatty liver disease (NAFLD), is a driver of NAFLD progression...
Autores principales: | Miyake, Teruki, Yoshida, Osamu, Matsuura, Bunzo, Furukawa, Shinya, Hirooka, Masashi, Abe, Masanori, Tokumoto, Yoshio, Koizumi, Yohei, Watanabe, Takao, Takeshita, Eiji, Sunago, Kotaro, Yukimoto, Atsushi, Watanabe, Kyoko, Miyazaki, Masumi, Kanzaki, Sayaka, Nakaguchi, Hironobu, Koizumu, Mitsuhito, Yamamoto, Yasunori, Kumagi, Teru, Hiasa, Yoichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076799/ https://www.ncbi.nlm.nih.gov/pubmed/35312970 http://dx.doi.org/10.1007/s13300-022-01239-7 |
Ejemplares similares
-
Plasma Fatty Acid Composition Is Associated with Histological Findings of Nonalcoholic Steatohepatitis
por: Miyake, Teruki, et al.
Publicado: (2022) -
Role of B Cell-Activating Factor in Fibrosis Progression in a Murine Model of Non-Alcoholic Steatohepatitis
por: Kanemitsu-Okada, Kozue, et al.
Publicado: (2023) -
Relationship between body composition and the histology of non‐alcoholic fatty liver disease: a cross‐sectional study
por: Miyake, Teruki, et al.
Publicado: (2021) -
Treatment on the Spleen Prevents the Progression of Secondary Sarcopenia in Patients With Liver Cirrhosis
por: Hirooka, Masashi, et al.
Publicado: (2020) -
Nonalcoholic fatty liver disease is a risk factor for glucose intolerance onset in men regardless of alanine aminotransferase status
por: Miyake, Teruki, et al.
Publicado: (2021)